Originally published August 29, 2010 at 9:55 p.m., updated August 4, 2010 at 5:51 p.m. BrainCells Inc., the San Diego-based developer of drugs for depression and other neurological disorders, said today it has acquired a drug from London-based Proximagen that could have potential against various psychiatric diseases.

Click Here to read the entire article...